[ad_1]
The European Medicines Agency (EMA) said Thursday that the vaccine was not associated with an overall increased risk of thromboembolism or blood clots. However, the head of the EVA pointed out that “the relationship between a rare type of blood clot and the vaccine cannot be definitively ruled out, so experts recommend encouraging doctors and those vaccinated to pay attention to the possible risks” .
However, as noted by immunologist M. Strioga, the situation is somewhat different for those with COVID-19.
“It is well known that if a coronavirus infection is not necessarily serious, then the risk of bleeding disorders, including thrombosis, increases initially and many times. And one of the main treatments applied to hospitalized patients and they are anticoagulants. This is a case of disease, and not necessarily the most serious disease, here it is confirmed that it is associated with this risk.
For vaccines, find that the logically explained causal relationship is not. Therefore, we can safely say that the benefits of this vaccine clearly outweigh the possible theoretical hypothetical risks and that vaccination should not be stopped. Because if it makes it more difficult and slows down the immunity of trying to build public immunity, the more severe the vaccination campaign, the more serious the consequences will be, especially if there are mutations in the virus ”, an oncologist at the National Cancer Institute. he told reporters Thursday.
Relevance to talk about vaccines for people who have already had the disease pokovidiniais EEA representatives also took note of residual events or those with an active infection at the time during a press conference.
According to the Head of the State Agency for Control of Medicines Gytis Andrulionis, from tomorrow additional precautions will be taken: it is planned to distribute the so-called letters to specialists, which will contain all the information that is important before prescribing AstraZeneca to patients.
“We will actively consult patients and specialists about adverse reactions to the vaccine, as well as other information. We will periodically evaluate the latest data with both the Ministry and the vaccination centers,” he explained.
I definitely can’t deny the connection
According to the VAS, a small number of rare and unusual but very serious vascular occlusion disorders began to be observed during the study and review they initiated, and a more detailed study was initiated.
It is reported that the clots formed can dislodge from the walls of blood vessels and be transported to the heart, brain, and lungs, clogging important blood vessels, causing strokes, heart attacks, or other dangerous conditions.
“Based on the available evidence and a thorough analysis of laboratory tests, clinical reports, autopsy results, and additional information from clinical trials over the days, we cannot unequivocally rule out a link between these cases and the vaccine, “explained Emmer Cooke, director of the EEA.
Blood clots were reported in at least 37 people who received AstraZeneca and four of them died. However, these cases represent only a small proportion of the 17 million. people vaccinated in Europe with at least one dose of this medicine.
The World Health Organization (WHO) said it had no evidence to suggest that these cases were caused by the AstraZeneca vaccine and emphasized that the benefits of the vaccine outweigh the potentially small risks. The vaccine manufacturer also found no increased risk of blood clots.
He was glad he took security seriously.
At the same time, immunologist M. Strioga welcomed the good news that vaccine safety is taken seriously.
“So far, there have been a number of statements from antivirals and other hostile people who are trying to pressure, almost by force, to offer unsafe, untested and possibly experimental vaccines. Also, that the goal is to vaccinate as much as possible at risk. potential security, and we can see that this is not being done. Because even in the face of the slightest suspicion and even in the absence of a scientifically substantiated direct connection between the facts, this campaign is carried out, representatives are summoned of the highest institutions ”, he pointed out.
The portal tv3.lt recalls that the Minister of Health Arūnas Dulkys announced that on Friday the vaccination with this vaccine will be renewed and those who wish will be able to choose which vaccine to use.
The decision follows findings from the European Medicines Agency on Thursday that the AstraZeneca vaccine is safe and effective, despite reports of blood clots in some people who have been vaccinated.
According to the Department of Statistics, the first dose of COVID-19 was vaccinated to 2,452 people last day, and the second dose was to 6,926 people. A total of 269 thousand people were vaccinated with the first dose in the country. 135 people, both doses – 111 thousand. 907 person.
[ad_2]
